The FTC opened an investigation in June 2022 into six large PBMs: CVS Caremark, Express Scripts, OptumRx, Humana, Prime ...
The news comes just one day after the FTC announced it had completed a two-year investigation into the industry. Pharmacy ...
Federal regulators plan to sue the top three pharmacy-benefit managers over how they negotiate prices for drugs, including ...
Antitrust regulators are set to file suit against CVS Caremark, Express Scripts and Optum Rx over how they negotiate discounts for drugs, including insulin, per the report.
The U.S. Federal Trade Commission is planning to sue UnitedHealth, Cigna and CVS Health over their tactics as middlemen in ...
The agency plans to file lawsuits targeting the business practices related to rebates brokered with drug manufacturers, the Journal reported.
Preparations to sue follow a two-year probe into whether the firms steer patients away from less-expensive medicines.
Pharmacy benefit managers (PBMs) wield enormous power on the accessibility and affordability of prescription drugs, and a ...